Reach Us +1-947-333-4405


Editor - Amol Suryawanshi | Tufts University | 13820
ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

World Congress on Pathology and Microbiology

Manila, Philippines
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Amol Suryawanshi

Amol Suryawanshi
Amol Suryawanshi
Department of Ophthalmology
Tufts University
Tufts University


Dr. Suryawanshi received his DVM degree from Bombay Veterinary College, India and MS in Biochemistry from Indian Veterinary Research Institute, India. He then completed his PhD in Comparative & Experimental Medicine at the College of Veterinary Medicine, The University of Tennessee. His doctoral research work focused on understanding the role of IL-17A and Th17 cells in herpes simplex virus 1-induced corneal Immunopathology. As a postdoctoral research fellow at Tufts University School of Medicine, he is studying the role of host innate and adaptive immune response in mediating corneal pathology and vision impairment against various microbial infections of the cornea.

Research Interest

Host Pathogen Interaction and associated immunopathology. Infectious Blindness, Angiogenesis, Inflammation, Corneal Immunopathology, Infectious Diseases. Identifying novel molecular and cellular targets for pharmacological intervention of inflammatory conditions.



Global Speakers in the subject

Global Experts in the subject